| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 40, 265-267, Copyright © 1975 by Endocrine Society
ARTICLES |
GR Cunningham, EM Caperton Jr and JW Goldzieher
A single dose of triamcinolone acetonide had antiovulatory properties in 7 of 11 women when injected on day 1 or 2 of the menstrual cycle. Daily blood studies in three subjects revealed that the FSH and LH surges were absent, and there was no rise in plasma progesterone. Follicular function, as manifested by estrogen levels, was maintained.
This article has been cited by other articles:
![]() |
M. Irahara, M. Ando, J. Sirois, J. Saito, and E. Y. Adashi Glucocorticoid Receptor-Mediated Post-Ceramide Inhibition of the Interleukin-1ß-Dependent Induction of Ovarian Prostaglandin Endoperoxide Synthase-2 in Rats Biol Reprod, April 1, 1999; 60(4): 946 - 953. [Abstract] [Full Text] |
||||
![]() |
J. M A MENS, A N. DE WOLF, B. J BERKHOUT, and H. J STAM Disturbance of the menstrual pattern after local injection with triamcinolone acetonide Ann Rheum Dis, November 1, 1998; 57(11): 700 - 700. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |